Veterinary Drugs Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Veterinary Drugs Market Analysis
The Veterinary Drugs Market is expected to witness a CAGR of 5.8% during the forecast period.
The impact of COVID-19 in its initial phase was adverse owing to disruption in veterinary services worldwide. For instance, the survey conducted by the Office for the Coordination of Humanitarian Affairs (OCHA), titled "Impact of COVID-19 on the delivery of veterinary services and animal disease reporting: (May-June 2020/June-August 2020)" was published in July 2021 stated that 93% participants reported that COVID-19 negatively impacted veterinary services and 70% participants stated the difficulty for field agents in conducting surveillance activities and field investigations. The participants included national animal disease reporting officers from the field, central veterinary services officers, and laboratory officers involved in disease reporting. However, the market gained traction as treatment, elective procedures, and pet and animal adoption increased in the latter phase of the pandemic. For instance, an article titled "Did the COVID-19 Pandemic Spark a Public Interest in Pet Adoption?" was published in Frontiers in Veterinary Sciences Journal in May 2021, stated that the global relative search volume (RSV) for pet, dog, and cat adoption peaked in April and May 2020. The RSV ratio (2020/2019) for both dog and cat adoption increased by up to 250% when compared with the preceding global average RSV for the same time period. This is likely to result in rising veterinary healthcare expenditure and ultimately cause a positive impact on the veterinary drug market.
In addition, the rise in the prevalence of infectious diseases in pets and farm animals, the increasing incidence and emergence of new technologies, especially in biologics, and increased demand for meat and animal-based products in agriculture and human healthcare are actively affecting the growth of the studied market.
The outbreak of Lumpy Skin Disease (LSD), a viral disease in certain regions of the world is expected to expedite the research and development of vaccines and drugs by various companies and ultimately boost market growth during the forecast period. For instance, according to the World Organization for Animal Health's July 2022 update, outbreaks of lumpy skin disease were confirmed across continental Asia and many countries in South East Asia in 2020. Also, vaccination for LSD in cattle is currently being developed by Hester Biosciences Limited, India. The company is expected to commercially market the vaccine in FY 2021-2022 and has already secured the test permit for evaluating the safety and efficacy of the vaccine. Such outbreaks and research and development initiatives by the key market players are expected to boost the market growth.
Additionally, the innovation in veterinary drugs, increasing product approvals, along with partnerships and collaborations by key players are helping in the market growth. For instance, in August 2021, Elanco acquired Bayer Animal Health to extend its pet health product category, enhance portfolio mix transformation, and improve the balance between the farm animal and pet health product categories.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the lack of veterinarians and the use of counterfeit medicines are likely to impede the market growth.
Veterinary Drugs Market Trends
This section covers the major market trends shaping the Veterinary Drugs Market according to our research experts:
Parasiticides Segment is Expected to Witness Growth Over The Forecast Period.
Parasites have a detrimental effect on pets and animals as they survive by attacking them for nourishment and living in or on the body, benefiting from food and protection. Common parasites such as ticks, mosquitos, and fleas live outside the body on the skin or hidden in an animal's fur which harms the animal and can cause a disease outbreak.
The surge in the pet population and increasing incidences of parasites causing disease in cats, dogs, and other animals are likely to increase the utility of parasiticides by the caretakers for disease prevention and management. For instance, as per the Pet Food Manufacturers Association (PFMA), the United Kingdom 2021 report mentioned that 17 million (59%) households had pets in 2021 and PFMA 2022 report stated that an estimated 17.4 million (62%) households have pets in 2022. The results are based on a survey that included 5,093 participants in 2021 and 8,983 respondents in 2022. Also, an article titled "Toxocara canis and Toxocara cati in Stray Dogs and Cats in Bangkok, Thailand: Molecular Prevalence and Risk Factors" was published in Parasitologia Journal in April 2022, which stated that Toxocara canis and Toxocara cati are two of the most common parasitic roundworms that cause functional intestinal disorders in dogs and cats worldwide. The study reported the prevalence of Toxocara canis in stray dogs in European countries which was 5.4%, the global prevalence was 10.6% - 11.7%, and the estimated prevalence in South-East Asia was 6.8% - 18.2% in 2020. Thus, the high pet population and prevalence of parasitic diseases in cats, dogs, and other animals are projected to propel the use of parasiticides which is anticipated to boost the segment growth.
In addition, the surge in research and development activities for identifying new treatments, product launches, and approvals by the key market players is expected to boost the segment's growth. For instance, in July 2020, Boehringer Ingelheim launched two new products to their line of animal healthcare products: NexGard and Broadline in India. The two products offer thorough parasite removal for dogs and felines, respectively. Also, in July 2021 Vetoquinol launched Imoxi Parasiticide which is a topical, broad-spectrum ready-to-use preparation that protects against intestinal parasites, heartworms, and fleas in pets. Such launches are anticipated to augment the segment growth during the forecast period.
North America is Expected to Dominate the Veterinary Drugs Market Over The Forecast Period.
North America is expected to hold a significant market share in the global veterinary drugs market due to a rise in the prevalence of diseases in pets and animals, and the emergence of new technologies in this region.
According to the North American Pet Health Insurance Association (NAPHIA) 2022 report, the total number of pets insured in the United States in 2021 was 3.9 million, a 28% increase from 2020. The average accident and illness premium for dogs was USD 583 per year and USD 343 per year for cats in 2021. The largest share of insured pets resides in California, New York, and Florida. The most significant number of pets insured were dogs at 82% versus cats at 18% in 2021. It also stated that 432,533 pets were insured in 2021, a 22.7% increase since 2020 in Canada. The increasing care decisions of pet owners are making more veterinary visits, contributing to the growth of the veterinary drugs market in the region.
Additionally, the increasing prevalence of diseases in pets and animals, and birds are likely to propel the veterinary drug market in the region. For instance, in May 2022 the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed the presence of highly pathogenic avian influenza (HPAI) in a domestic flock of non-commercial poultry in Monmouth County, New Jersey. The same source reported that approximately 37.96 million birds had been infected as of May 2022. Thus, the surge in infectious diseases in birds is likely to expedite the research and development activities to develop new treatment which is likely to boost the veterinary drugs market in the region.
Moreover, increasing product launches and rising adoption of animals are fueling the growth of the overall regional market to a large extent. For instance, in April 2022, Pharmgate Inc. received Food and Drug Administration (FDA) approval for Pennitracin MD for the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens in broiler and replacement chickens. The surge in veterinary drugs launches to address various diseases in farm animals and pets are projected to augment the market growth in the region.
Therefore, owing to the above-mentioned factors, the growth of the studied market is anticipated in the North America Region.
Veterinary Drugs Industry Overview
The veterinary drugs market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. Some of the companies which are currently dominating the market are Bayer AG, Zoetis Inc., Virbac S.A, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol S.A, Merck & Co., Inc., Elanco, Bimeda, Inc (Bimeda Holdings PLC), Norbrook, Hester Biosciences Limited, and Sequent Scientific Limited among others
Veterinary Drugs Market Leaders
-
Zoetis
-
Elanco
-
Virbac S.A
-
Boehringer Ingelheim International GmbH (Merial)
-
Vetoquinol S.A
*Disclaimer: Major Players sorted in no particular order
Veterinary Drugs Market News
- In April 2022, Elanco Animal Health Incorporated and Ginkgo Bioworks launched a new company, BiomEdit, a microbiome innovation company. The new company launch aims to produce and market innovative probiotics, bioactive compounds, engineered microbial therapeutics, and monitoring services for animal health.
- In January 2022, the United States Food and Drug Administration approved Zoetis's Solensia (frunevetmab injection) to treat cat osteoarthritis pain.
Veterinary Drugs Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Prevalence of Infectious Diseases in Pets and Farm Animals
4.2.2 Emergence of New Technologies, especially in Biologics
4.2.3 Increased Demand for Meat and Animal-based Products in Agriculture and Human Healthcare
4.3 Market Restraints
4.3.1 Lack of Veterinarians
4.3.2 Use of Counterfeit Medicines
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Anti-infectives
5.1.2 Anti-inflammatory
5.1.3 Parasiticides
5.1.4 Vaccines
5.1.5 Other Types
5.2 By Route of Administration
5.2.1 Oral
5.2.2 Parenteral
5.2.3 Topical
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Zoetis Inc.
6.1.3 Virbac S.A
6.1.4 Boehringer Ingelheim International GmbH (Merial)
6.1.5 Elanco
6.1.6 Ceva
6.1.7 Vetoquinol S.A
6.1.8 Bimeda, Inc (Bimeda Holdings PLC)
6.1.9 Merck & Co., Inc.
6.1.10 Hester Biosciences Limited
6.1.11 Norbrook
6.1.12 Sequent Scientific Limited
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Veterinary Drugs Industry Segmentation
As per the scope of the report, veterinary drugs are used to treat numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals, and hormones are developed in order to minimize the attack of harmful viruses and bacterial parasites in animals. The Veterinary Drugs Market is segmented by Product Type (Anti-infectives, Anti-inflammatory, Parasiticides, Vaccines, and Others), Route of Administration (Oral, Parenteral, and Topical), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Anti-infectives | |
| Anti-inflammatory | |
| Parasiticides | |
| Vaccines | |
| Other Types |
| By Route of Administration | |
| Oral | |
| Parenteral | |
| Topical |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Veterinary Drugs Market Research FAQs
What is the current Global Veterinary Drugs Market size?
The Global Veterinary Drugs Market is projected to register a CAGR of 5.80% during the forecast period (2024-2029)
Who are the key players in Global Veterinary Drugs Market?
Zoetis, Elanco, Virbac S.A, Boehringer Ingelheim International GmbH (Merial) and Vetoquinol S.A are the major companies operating in the Global Veterinary Drugs Market.
Which is the fastest growing region in Global Veterinary Drugs Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Veterinary Drugs Market?
In 2024, the North America accounts for the largest market share in Global Veterinary Drugs Market.
What years does this Global Veterinary Drugs Market cover?
The report covers the Global Veterinary Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Veterinary Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Veterinary Drugs Industry Report
The global market for veterinary compounds is segmented by product type, route of administration, and geography. The product types include anti-infectives, anti-inflammatory agents, parasiticides, vaccines, and others. The routes of administration are oral, parenteral, and topical. The market is geographically segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.
The industry report provides an in-depth market analysis, including market share, market size, and market growth. The market trends indicate a significant growth rate, driven by the increasing demand for veterinary drugs. The industry research highlights the key market leaders and their contributions to the market value. The market data and industry statistics offer valuable insights into the market segmentation and market outlook.
The industry reports also include a market forecast, predicting the market's future trajectory. The market review and market predictions are based on comprehensive industry information and industry research. The report example and report pdf provide a detailed industry overview and market overview. The industry outlook and market forecast suggest a positive trend for the veterinary drugs market.
The research companies involved in the market analysis have provided a thorough industry analysis, including industry trends and industry sales. The industry size and market segmentation are crucial for understanding the market dynamics. The market leaders play a significant role in shaping the market growth and market outlook. The market review and market predictions are essential for stakeholders to make informed decisions.
Overall, the veterinary drugs market is poised for substantial growth, with a positive industry outlook and promising market trends. The market value and market data indicate a robust future for the industry, supported by comprehensive industry research and market analysis. The report pdf and report example offer a detailed overview of the market, making it a valuable resource for industry stakeholders.
